Sionna Therapeutics (SION) Other Non-Current Assets (2024 - 2026)
Quarterly results put Other Non-Current Assets at $585000.0 for Q1 2026, down 39.19% from a year ago — trailing twelve months through Mar 2026 was $585000.0 (down 39.19% YoY), and the annual figure for FY2025 was $963000.0, down 3.7%.
Sionna Therapeutics has reported Other Non-Current Assets over the past 3 years, most recently at $585000.0 for Q1 2026.
- Other Non-Current Assets reached $585000.0 in Q1 2026 per SION's latest filing, down from $963000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.0 million in Q4 2024 and bottomed at $585000.0 in Q1 2026.
- Median Other Non-Current Assets over the past 3 years was $962000.0 (2024), compared with a mean of $913714.3.
- The largest annual shift saw Other Non-Current Assets changed 0.0% in 2025 before it plummeted 39.19% in 2026.
- Over 3 years, Other Non-Current Assets stood at $1.0 million in 2024, then decreased by 3.7% to $963000.0 in 2025, then tumbled by 39.25% to $585000.0 in 2026.
- Business Quant data shows Other Non-Current Assets for SION at $585000.0 in Q1 2026, $963000.0 in Q4 2025, and $962000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.13 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 585,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 585,000.00 |
| Dec 31, 2025 | 963,000.00 |
| Mar 31, 2025 | 962,000.00 |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 962,000.00 |
| Jun 30, 2024 | 962,000.00 |
| Mar 31, 2024 | 962,000.00 |